Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Daisy Alapat

Concepts (246)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
27
2024
2910
1.790
 Why?
Flow Cytometry
5
2018
470
0.910
 Why?
Immunoglobulins
2
2018
79
0.720
 Why?
Immunoglobulin kappa-Chains
2
2016
22
0.650
 Why?
Bone Marrow
7
2022
362
0.600
 Why?
DNA, Neoplasm
1
2018
147
0.590
 Why?
Hematopoietic Stem Cell Transplantation
4
2024
553
0.570
 Why?
Lymphoma, Large B-Cell, Diffuse
2
2015
105
0.550
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2016
55
0.530
 Why?
Immunoglobulin lambda-Chains
1
2015
15
0.520
 Why?
Gene Rearrangement, B-Lymphocyte
1
2015
6
0.500
 Why?
Receptors, Antigen, B-Cell
1
2015
7
0.500
 Why?
Plasma Cells
2
2016
223
0.480
 Why?
Neoplasm, Residual
5
2022
166
0.460
 Why?
Plasmacytoma
3
2022
42
0.410
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2012
10
0.400
 Why?
Cell Differentiation
1
2015
653
0.400
 Why?
Lymphoma, Mantle-Cell
1
2012
19
0.400
 Why?
Humans
46
2024
49827
0.380
 Why?
Carcinoembryonic Antigen
1
2011
15
0.380
 Why?
Calcitonin
1
2011
30
0.380
 Why?
Antigens, CD
1
2012
215
0.370
 Why?
Carcinoma
1
2011
137
0.340
 Why?
Myogenin
1
2008
6
0.330
 Why?
Muscle Fibers, Slow-Twitch
1
2008
12
0.330
 Why?
Muscle Fibers, Fast-Twitch
1
2008
14
0.330
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2022
103
0.320
 Why?
Paraproteinemias
2
2022
72
0.310
 Why?
Middle Aged
17
2024
11997
0.290
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
987
0.290
 Why?
Neoplasms, Second Primary
2
2019
69
0.280
 Why?
Tumor Microenvironment
3
2023
210
0.260
 Why?
Prognosis
7
2024
1952
0.260
 Why?
Gene Expression Profiling
3
2016
1031
0.260
 Why?
Treatment Outcome
10
2022
5138
0.250
 Why?
Pancytopenia
3
2016
37
0.240
 Why?
Gastrointestinal Neoplasms
1
2022
44
0.210
 Why?
Aged
15
2024
9272
0.200
 Why?
Female
19
2024
26329
0.200
 Why?
Embolization, Therapeutic
2
2021
87
0.200
 Why?
Male
16
2024
25093
0.200
 Why?
Neoplasms, Plasma Cell
2
2020
37
0.200
 Why?
Thrombocytopenia
1
2022
84
0.190
 Why?
Cryosurgery
1
2021
36
0.190
 Why?
Chromosome Deletion
2
2023
141
0.190
 Why?
Skin Neoplasms
2
2016
487
0.180
 Why?
Transplantation, Autologous
4
2024
456
0.180
 Why?
Combined Modality Therapy
1
2021
636
0.170
 Why?
Ploidies
1
2018
11
0.160
 Why?
Hematopoietic Stem Cells
1
2019
184
0.150
 Why?
Leukemia, Myeloid, Acute
1
2019
183
0.150
 Why?
Kidney Diseases
1
2020
214
0.150
 Why?
Herpesvirus 8, Human
1
2019
91
0.150
 Why?
Sarcoma, Myeloid
1
2017
19
0.150
 Why?
Chromosomes, Human, Pair 17
1
2017
36
0.150
 Why?
Immunohistochemistry
3
2016
971
0.140
 Why?
Lymph Nodes
2
2019
264
0.140
 Why?
Amyloidosis
2
2016
78
0.140
 Why?
Cell Cycle
1
2018
232
0.140
 Why?
CA-125 Antigen
1
2016
17
0.140
 Why?
Skin Diseases, Infectious
1
2016
8
0.140
 Why?
Leukemia, Promyelocytic, Acute
1
2016
11
0.140
 Why?
Anemia, Aplastic
1
2016
12
0.140
 Why?
Myeloproliferative Disorders
1
2016
27
0.130
 Why?
Tumor Suppressor Protein p53
1
2017
202
0.130
 Why?
Electrophoresis, Capillary
1
2015
11
0.130
 Why?
In Situ Hybridization
1
2015
65
0.130
 Why?
V(D)J Recombination
1
2015
4
0.130
 Why?
Immunophenotyping
1
2015
109
0.130
 Why?
RNA, Messenger
2
2015
1105
0.120
 Why?
Diagnosis, Differential
3
2016
1036
0.120
 Why?
Fatal Outcome
1
2015
195
0.120
 Why?
Bone Marrow Transplantation
2
2022
116
0.120
 Why?
Immunoglobulin Light Chains
1
2015
81
0.120
 Why?
Prealbumin
1
2014
21
0.120
 Why?
Bone Marrow Neoplasms
1
2014
13
0.120
 Why?
Neoplasm Proteins
1
2016
323
0.120
 Why?
Hodgkin Disease
1
2014
45
0.110
 Why?
Polymerase Chain Reaction
1
2015
455
0.110
 Why?
Adult
8
2024
13160
0.110
 Why?
Parvoviridae Infections
1
2013
20
0.110
 Why?
Parvovirus B19, Human
1
2013
17
0.110
 Why?
Partial Thromboplastin Time
1
2012
12
0.110
 Why?
Prothrombin Time
1
2012
18
0.110
 Why?
Cardiomyopathies
1
2014
108
0.110
 Why?
Immunoglobulins, Intravenous
1
2013
54
0.110
 Why?
Afibrinogenemia
1
2012
5
0.110
 Why?
Predictive Value of Tests
1
2015
904
0.110
 Why?
Phenotype
1
2015
727
0.100
 Why?
Plasma Exchange
1
2012
23
0.100
 Why?
Retroperitoneal Neoplasms
1
2012
18
0.100
 Why?
Glycoproteins
1
2012
115
0.100
 Why?
Gene Expression Regulation, Neoplastic
1
2016
829
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2012
8
0.100
 Why?
Longitudinal Studies
2
2024
673
0.100
 Why?
Histoplasma
1
2011
27
0.100
 Why?
Antigens, Fungal
1
2011
24
0.100
 Why?
Immunoenzyme Techniques
1
2011
143
0.100
 Why?
Hepatitis C
1
2012
77
0.100
 Why?
Histoplasmosis
1
2011
50
0.090
 Why?
Carcinoma, Neuroendocrine
1
2011
24
0.090
 Why?
In Situ Hybridization, Fluorescence
3
2023
252
0.090
 Why?
Registries
2
2024
518
0.090
 Why?
Dose-Response Relationship, Drug
2
2016
1374
0.090
 Why?
Splenic Neoplasms
1
2009
2
0.090
 Why?
Disease Progression
3
2022
822
0.090
 Why?
Thyroid Neoplasms
1
2011
109
0.080
 Why?
Gene Expression
1
2012
608
0.080
 Why?
Myelodysplastic Syndromes
1
2009
80
0.080
 Why?
Retrospective Studies
4
2024
6117
0.080
 Why?
Mutagenesis, Site-Directed
1
2008
99
0.080
 Why?
Hemangioma
1
2009
83
0.080
 Why?
Aged, 80 and over
4
2019
3125
0.080
 Why?
HIV Infections
1
2012
354
0.080
 Why?
Tomography, X-Ray Computed
3
2023
1159
0.080
 Why?
Survival Analysis
2
2021
659
0.070
 Why?
Cells, Cultured
2
2008
1571
0.070
 Why?
Protein Processing, Post-Translational
1
2008
171
0.070
 Why?
Stem Cell Transplantation
2
2022
181
0.070
 Why?
Graft vs Host Disease
1
2007
74
0.070
 Why?
Positron-Emission Tomography
2
2021
294
0.070
 Why?
Muscle Proteins
1
2008
303
0.070
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2005
34
0.060
 Why?
Semaphorin-3A
1
2004
2
0.060
 Why?
Nerve Degeneration
1
2004
24
0.060
 Why?
p38 Mitogen-Activated Protein Kinases
1
2005
96
0.060
 Why?
Acid Anhydride Hydrolases
1
2004
15
0.060
 Why?
Antineoplastic Agents
1
2013
1172
0.060
 Why?
Mitogen-Activated Protein Kinase 3
1
2004
50
0.060
 Why?
Mitogen-Activated Protein Kinase 1
1
2004
51
0.060
 Why?
Muscle, Smooth, Vascular
1
2005
131
0.060
 Why?
Imidazoles
1
2005
119
0.060
 Why?
Ferritins
1
2024
29
0.060
 Why?
Pyridines
1
2005
130
0.060
 Why?
Myeloid Progenitor Cells
1
2023
18
0.060
 Why?
Pyrimidines
1
2005
191
0.060
 Why?
Cost of Illness
1
2024
117
0.060
 Why?
Gene Expression Regulation
1
2008
979
0.060
 Why?
Adrenal Cortex Hormones
1
2023
93
0.050
 Why?
Enzyme Inhibitors
1
2005
391
0.050
 Why?
Chromosomes, Human, Pair 1
1
2023
93
0.050
 Why?
Hippocampus
1
2004
228
0.050
 Why?
Case-Control Studies
2
2019
1128
0.050
 Why?
Cohort Studies
2
2020
1422
0.050
 Why?
Dexamethasone
1
2024
429
0.050
 Why?
Mediastinum
1
2021
22
0.050
 Why?
Gastrointestinal Tract
1
2022
103
0.050
 Why?
Chromosome Aberrations
1
2023
298
0.050
 Why?
Vincristine
1
2021
89
0.050
 Why?
Fever
1
2022
117
0.050
 Why?
Axilla
1
2021
89
0.050
 Why?
T-Lymphocytes
1
2023
338
0.050
 Why?
Neurons
1
2004
459
0.050
 Why?
Prednisone
1
2021
99
0.050
 Why?
Pelvis
1
2021
68
0.050
 Why?
Alzheimer Disease
1
2004
317
0.050
 Why?
Signal Transduction
2
2004
1617
0.050
 Why?
Cyclophosphamide
1
2021
165
0.050
 Why?
Time Factors
2
2017
2912
0.050
 Why?
Radiopharmaceuticals
1
2021
209
0.050
 Why?
Fluorodeoxyglucose F18
1
2021
191
0.050
 Why?
Tumor Burden
1
2020
132
0.050
 Why?
Hospitalization
1
2024
653
0.040
 Why?
Doxorubicin
1
2021
230
0.040
 Why?
Mice
3
2023
5720
0.040
 Why?
Antibodies, Monoclonal
1
2023
458
0.040
 Why?
False Negative Reactions
1
2019
29
0.040
 Why?
Adolescent
1
2011
6340
0.040
 Why?
Herpesvirus 4, Human
1
2019
35
0.040
 Why?
Cell Line, Tumor
1
2023
1402
0.040
 Why?
Epstein-Barr Virus Infections
1
2019
31
0.040
 Why?
Herpesviridae Infections
1
2019
46
0.040
 Why?
Phosphorylation
3
2005
536
0.040
 Why?
Virus Diseases
1
2019
40
0.040
 Why?
Genome, Viral
1
2019
79
0.040
 Why?
DNA, Viral
1
2019
133
0.040
 Why?
Follow-Up Studies
1
2024
2179
0.040
 Why?
Neoplasm Recurrence, Local
1
2022
618
0.040
 Why?
Liver
1
2022
1109
0.030
 Why?
Scleromyxedema
1
2016
4
0.030
 Why?
Schnitzler Syndrome
1
2016
4
0.030
 Why?
Xanthomatosis
1
2016
9
0.030
 Why?
Cryoglobulinemia
1
2016
13
0.030
 Why?
Asymptomatic Diseases
1
2016
36
0.030
 Why?
POEMS Syndrome
1
2016
32
0.030
 Why?
Melphalan
1
2016
174
0.030
 Why?
Disease-Free Survival
1
2016
457
0.030
 Why?
Animals
3
2023
13150
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
181
0.030
 Why?
Reed-Sternberg Cells
1
2014
2
0.030
 Why?
HIV Seronegativity
1
2014
3
0.030
 Why?
Karyotype
1
2014
18
0.030
 Why?
Fusion Proteins, bcr-abl
1
2014
20
0.030
 Why?
Thalidomide
1
2016
374
0.030
 Why?
Cell Division
2
2005
292
0.030
 Why?
Heterozygote
1
2014
82
0.030
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2014
44
0.030
 Why?
Mutation
1
2019
1293
0.030
 Why?
Remission Induction
1
2014
207
0.030
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
595
0.030
 Why?
Oligonucleotide Array Sequence Analysis
1
2015
412
0.030
 Why?
Fibrinogen
1
2012
31
0.030
 Why?
Blood Coagulation
1
2012
57
0.030
 Why?
Risk Assessment
1
2017
1262
0.030
 Why?
Survival Rate
1
2015
905
0.030
 Why?
Neoplasm Staging
1
2015
746
0.030
 Why?
Reference Values
1
2012
310
0.030
 Why?
Biopsy
1
2014
582
0.030
 Why?
Antibodies, Fungal
1
2011
4
0.020
 Why?
Mycological Typing Techniques
1
2011
3
0.020
 Why?
Cross Reactions
1
2011
41
0.020
 Why?
Lung Diseases, Fungal
1
2011
31
0.020
 Why?
Immunocompromised Host
1
2011
120
0.020
 Why?
Splenectomy
1
2009
34
0.020
 Why?
Severity of Illness Index
1
2012
942
0.020
 Why?
Sensitivity and Specificity
1
2011
854
0.020
 Why?
Blood Transfusion
1
2009
121
0.020
 Why?
Transplantation, Isogeneic
1
2007
2
0.020
 Why?
Laparoscopy
1
2009
173
0.020
 Why?
Mice, Inbred C3H
1
2007
81
0.020
 Why?
Cyclosporine
1
2007
64
0.020
 Why?
Mice, SCID
1
2007
175
0.020
 Why?
Magnetic Resonance Imaging
1
2014
1533
0.020
 Why?
Models, Animal
1
2007
233
0.020
 Why?
Immunosuppressive Agents
1
2007
220
0.020
 Why?
Macromolecular Substances
1
2004
35
0.020
 Why?
Physical Chromosome Mapping
1
2004
8
0.020
 Why?
tau Proteins
1
2004
26
0.020
 Why?
Genetic Complementation Test
1
2004
48
0.020
 Why?
Epitopes
1
2004
59
0.020
 Why?
Epidermal Growth Factor
1
2004
35
0.020
 Why?
Cricetulus
1
2004
97
0.020
 Why?
Catalytic Domain
1
2004
57
0.020
 Why?
Microtubule-Associated Proteins
1
2004
67
0.010
 Why?
Mutagenesis
1
2004
60
0.010
 Why?
Cricetinae
1
2004
192
0.010
 Why?
Cloning, Molecular
1
2004
189
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2004
104
0.010
 Why?
Receptors, Cell Surface
1
2004
121
0.010
 Why?
RNA
1
2004
170
0.010
 Why?
Cell Survival
1
2005
598
0.010
 Why?
Amino Acid Sequence
1
2004
587
0.010
 Why?
Molecular Sequence Data
1
2004
797
0.010
 Why?
Nerve Tissue Proteins
1
2004
193
0.010
 Why?
Mice, Inbred C57BL
1
2007
1806
0.010
 Why?
Cell Line
1
2004
1002
0.010
 Why?
Alapat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (246) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department